The Allergen Specific IgE Tests segmentation by application distinguishes four principal clinical domains: Respiratory Allergies, Food Allergies, Insect Venom Allergies, and Drug‑Induced Allergies. Respiratory allergies—primarily asthma, allergic rhinitis, and chronic sinusitis—represent the largest share, accounting for roughly 45 % of total test volumes, driven by high prevalence and routine monitoring requirements. Food allergies, covering IgE‑mediated reactions to peanuts, tree nuts, shellfish, and dairy, contribute about 30 % of market activity, reflecting increased diagnostic demand after rising incidence rates. Insect venom allergies, largely due to hymenoptera stings, occupy 15 % of the market, supported by specialized testing for occupational and travel‑related exposures. Drug‑induced IgE responses, including reactions to antibiotics and biologics, comprise the remaining 10 %, a niche yet growing segment as personalized medicine expands. Collectively, these application categories shape the overall Allergen Specific IgE Tests market size by allocating resources, R&D focus, and pricing structures in proportion to their clinical burden.